Search Results - "Witchell, Donna"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice[S] by Mullick, Adam E., Fu, Wuxia, Graham, Mark J., Lee, Richard G., Witchell, Donna, Bell, Thomas A., Whipple, Charles P., Crooke, Rosanne M.

    Published in Journal of lipid research (01-05-2011)
    “…Chronic elevations of plasma apolipoprotein B (apoB) are strongly associated with cardiovascular disease. We have previously demonstrated that inhibition of…”
    Get full text
    Journal Article
  2. 2

    Specific Inhibition of PTEN Expression Reverses Hyperglycemia in Diabetic Mice by BUTLER, Madeline, MCKAY, Robert A, POPOFF, Ian J, GAARDE, William A, WITCHELL, Donna, MURRAY, Susan F, DEAN, Nicholas M, BHANOT, Sanjay, MONIA, Brett P

    Published in Diabetes (New York, N.Y.) (01-04-2002)
    “…Specific Inhibition of PTEN Expression Reverses Hyperglycemia in Diabetic Mice Madeline Butler , Robert A. McKay , Ian J. Popoff , William A. Gaarde , Donna…”
    Get full text
    Journal Article
  3. 3

    Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis by Myers, Kathleen J, Murthy, Sreekant, Flanigan, Anne, Witchell, Donna R, Butler, Madeline, Murray, Susan, Siwkowski, Andrew, Goodfellow, Deborah, Madsen, Karen, Baker, Brenda

    “…Tumor necrosis factor-alpha (TNF-alpha) is a key cytokine involved in the pathogenesis of inflammatory bowel disease. We have developed a second-generation…”
    Get more information
    Journal Article
  4. 4

    Antisense oligonucleotide blockade of alpha 4 integrin prevents and reverses clinical symptoms in murine experimental autoimmune encephalomyelitis by Myers, Kathleen J., Witchell, Donna R., Graham, Mark J., Koo, Seongjoon, Butler, Madeline, Condon, Thomas P.

    Published in Journal of neuroimmunology (01-03-2005)
    “…We investigated the use of an antisense oligonucleotide (ASO) specific for mRNA of the alpha chain (CD49d) of mouse VLA-4 to down-regulate VLA-4 expression and…”
    Get full text
    Journal Article
  5. 5

    Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice by Butler, M, Crooke, R M, Graham, M J, Lemonidis, K M, Lougheed, M, Murray, S F, Witchell, D, Steinbrecher, U, Bennett, C F

    “…It has been suggested that binding of phosphorothioate oligodeoxynucleotides (P=S ODNs) to macrophage scavenger receptors (SR-AI/II) is the primary mechanism…”
    Get more information
    Journal Article
  6. 6

    Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals by Seth, Punit P, Siwkowski, Andrew, Allerson, Charles R, Vasquez, Guillermo, Lee, Sam, Prakash, Thazha P, Wancewicz, Edward V, Witchell, Donna, Swayze, Eric E

    Published in Journal of medicinal chemistry (08-01-2009)
    “…The potency of second generation antisense oligonucleotides (ASOs) in animals was increased 3- to 5 -fold (ED50 ≈ 2−5 mg/kg) without producing hepatotoxicity,…”
    Get full text
    Journal Article
  7. 7

    Selective Abrogation of STAT5 Expression Impairs the Proliferation of Acute Myeloid Leukemia Cells with Various Cytogenetic Alterations by Kim, Youngsoo, Zhou, Tianyuan, Guo, Shuling, Siwkowski, Andy, Witchell, Donna, Pandey, Sanjay, Monia, Brett P.

    Published in Blood (16-11-2008)
    “…STAT5 is a key common downstream mediator of multiple signaling pathways which are often dysregulated in various hematologic malignancies, including acute…”
    Get full text
    Journal Article
  8. 8

    A Sense Oligonucleotide Specifically Reverses the Prothrombin Depletion and Anticoagulation Caused by ISIS 401025, an Antisense Oligonucleotide Targeting Prothrombin RNA in Mice by Zhao, Chenguang, Monia, Brett P., Siwkowski, Andy, Freier, Sue, Witchell, Donna, Zhang, Hong

    Published in Blood (16-11-2007)
    “…The ability to safely and effectively neutralize anticoagulant activity is of particular importance in the case of long acting drugs. While antisense…”
    Get full text
    Journal Article
  9. 9

    Antisense Strategies to Specifically Deplete Levels of Factors II, VII and IX in Mice To Assess Their Potential as Targets for Anticoagulation by Zhang, Hong, Zhao, Chenguang, Crosby, Jeff, Siwkowski, Andy, Freier, Sue, Witchell, Donna, Monia, Brett P.

    Published in Blood (16-11-2007)
    “…Numerous potential intervention points exist within coagulation pathways for development of novel anticoagulant agents. To help determine the most suitable…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo by Shen, Lijiang, Siwkowski, Andrew, Wancewicz, Edward V, Lesnik, Elena, Butler, Madeline, Witchell, Donna, Vasquez, Guillermo, Ross, Bruce, Acevedo, Oscar, Inamati, Gopal, Sasmor, Henri, Manoharan, Muthiah, Monia, Brett P

    Published in Antisense & nucleic acid drug development (01-01-2003)
    “…Inclusion of C-5 propynyl pyrimidines in phosphorothioate antisense oligonucleotides (ASOs) has been shown to significantly increase their potency for…”
    Get more information
    Journal Article